BG
LGND icon

BlackRock Group’s Ligand Pharmaceuticals LGND Stock Holding History

BlackRock Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.02M Buy
63,375
+12,037
+23% +$760K ﹤0.01% 1310
2016
Q3 		$3.27M Sell
51,338
-665
-1% -$48.8K ﹤0.01% 1318
2016
Q2 		$3.87M Buy
52,003
+10,246
+25% +$760K ﹤0.01% 1202
2016
Q1 		$2.79M Sell
41,757
-1,184
-3% -$72K ﹤0.01% 1345
2015
Q4 		$2.9M Buy
42,941
+2,744
+7% +$169K ﹤0.01% 1299
2015
Q3 		$2.15M Sell
40,197
-2,374
-6% -$144K ﹤0.01% 1456
2015
Q2 		$2.68M Buy
42,571
+5,979
+16% +$326K ﹤0.01% 1404
2015
Q1 		$1.76M Sell
36,592
-9,094
-20% -$348K ﹤0.01% 1535
2014
Q4 		$1.52M Buy
45,686
+24,810
+119% +$807K ﹤0.01% 1625
2014
Q3 		$612K Sell
20,876
-6,999
-25% -$232K ﹤0.01% 2075
2014
Q2 		$1.08M Sell
27,875
-10,777
-28% -$437K ﹤0.01% 1779
2014
Q1 		$1.62M Sell
38,652
-7,431
-16% -$310K ﹤0.01% 1720
2013
Q4 		$1.51M Buy
46,083
+34,718
+305% +$1.13M ﹤0.01% 1728
2013
Q3 		$307K Buy
11,365
+9,562
+530% +$269K ﹤0.01% 2373
2013
Q2 		$42K Buy
+1,803
New +$32.4K ﹤0.01% 2457

Other funds holding LGND

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock Group's LGND Position: Q4 2016 in Review

BlackRock Group increased its Ligand Pharmaceuticals (LGND) stake by 23% in Q4 2016, buying an estimated $760K and bringing the position to 63,375 shares worth $4.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

BlackRock Group first reported a position in LGND in Q2 2013 and has held it in 15 quarters since. 269 funds tracked by Wall St. Rank hold LGND as of Q4 2016.

  • BlackRock Group held 63,375 shares of Ligand Pharmaceuticals worth $4.02M as of Q4 2016.
  • BlackRock Group bought 12,037 Ligand Pharmaceuticals shares in Q4 2016, an estimated $760K.
  • Ligand Pharmaceuticals made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1310 holding.
  • BlackRock Group first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 269 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.